A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone
NCT00097552 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1696
Last updated 2012-11-14
Summary
This study is a multicenter, open-label, observational, postmarketing surveillance study of Genentech growth hormone (GH) products in the treatment of girls with Turner syndrome in the United States and Canada.
Conditions
- Turner Syndrome
Sponsors & Collaborators
-
Genentech, Inc.
lead INDUSTRY
Principal Investigators
-
Barbara Lippe, M.D. · Genentech, Inc.
Eligibility
- Max Age
- 17 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-05-31
- Primary Completion
- 2010-07-31
- Completion
- 2010-07-31
More Related Trials
-
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
NCT01367834 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone Treatment of Women With Turner Syndrome
NCT00420654 ·Status: COMPLETED ·Phase: NA
-
Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature
NCT00121875 ·Status: TERMINATED
-
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
NCT01604395 ·Status: RECRUITING
-
A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome
NCT06722079 ·Status: COMPLETED
-
D3-GHR Polymorphism and Turner Syndrome
NCT00443144 ·Status: COMPLETED
-
Observational Study of Somatropin Treatment in Children
NCT01088412 ·Status: COMPLETED
-
A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome
NCT03189160 ·Status: UNKNOWN ·Phase: PHASE2
-
Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
NCT00097526 ·Status: COMPLETED
-
Genotropin Treatment In Very Young Children Born Small For Gestational Age
NCT00627523 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome
NCT00029159 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome
NCT00001343 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
NCT04798690 ·Status: RECRUITING
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
NCT00174278 ·Status: COMPLETED ·Phase: PHASE3
-
Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age
NCT00174252 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Assess the Efficacy and Safety of DA-3002
NCT01813630 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study
NCT01419249 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome
NCT05690386 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605 ·Status: COMPLETED ·Phase: PHASE3
-
Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
NCT00156143 ·Status: COMPLETED ·Phase: PHASE3
-
Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON
NCT01365351 ·Status: COMPLETED
-
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
NCT02616562 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy
NCT00174291 ·Status: TERMINATED ·Phase: PHASE3